연세대학교 원주세브란스기독병원은 1959년에 설립된 병원이다. 강원도 원주시 일산로 20에 위치하고 있다.

During the past decade, Wonju Severance Christian Hospital conducted 154 clinical trials. In the 10-year time frame, 154 clinical trials started and 35 clinical trials were completed, i.e. on average, 22.7% percent of trials that started reached the finish line to date. In the past 5 years, 65 clinical trials started and 29 clinical trials were completed. i.e. 44.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wonju Severance Christian Hospital" #1 sponsor was "Wonju Severance Christian Hospital" with 18 trials, followed by "Seung-Jung Park" with 15 trials sponsored, "Boehringer Ingelheim" with 11 trials sponsored, "Yonsei University" with 11 trials sponsored and "Hoffmann-La Roche" with 11 trials sponsored. Other sponsors include 131 different institutions and companies that sponsored additional 65 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wonju Severance Christian Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 19 trials as a collaborator, "Eli Lilly and Company" with 5 trials as a collaborator, "National Research Foundation of Korea" with 5 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator and "GlaxoSmithKline" with 3 trials as a collaborator. Other collaborators include 63 different institutions and companies that were collaborators in the rest 64 trials.

According to Clinical.Site data, the most researched conditions in "Wonju Severance Christian Hospital" are "Coronary Artery Disease" (22 trials), "Ulcerative Colitis" (16 trials), "Crohn's Disease" (8 trials), "Carbon Monoxide Poisoning" (6 trials) and "Crohn Disease" (6 trials). Many other conditions were trialed in "Wonju Severance Christian Hospital" in a lesser frequency.

Most popular intervention types in "Wonju Severance Christian Hospital" are "Drug" (125 trials), "Device" (24 trials), "Other" (21 trials), "Biological" (19 trials) and "Procedure" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (47 trials), "Aspirin" (5 trials), "Empagliflozin" (4 trials), "Etrasimod" (4 trials) and "Etrolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Wonju Severance Christian Hospital" are 195 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Wonju Severance Christian Hospital". undefined are not yet recruiting, 43 are recruiting, 22 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 87 completed trials in Wonju Severance Christian Hospital, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Wonju Severance Christian Hospital, 2 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 80 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 27 trials, and there were also 18 trials that are defined as “Not Applicable".